Nanobiotix S.A Cash Flow Conversion Efficiency

Latest as of June 2025: 0.253x

Nanobiotix S.A cash flow conversion efficiency. Based on the latest financial reports, Nanobiotix S.A (NANO) has a cash flow conversion efficiency ratio of 0.253x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.41 Million ≈ $-20.36 Million USD) by net assets (€-68.95 Million ≈ $-80.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nanobiotix S.A (2011–2024)

Cash flow conversion efficiency of Nanobiotix S.A from 2011 to 2024. This chart illustrates how Nanobiotix S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nanobiotix S.A (NANO) stock price for real-time trading data and today's change.

Nanobiotix S.A Cash Flow Conversion Ratio Explained

Nanobiotix S.A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nanobiotix S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanobiotix S.A ranked by their cash flow conversion efficiency. Also see Nanobiotix S.A (NANO) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Precision Drilling Corporation TO:PD	0.039x
Chongqing Iron & Steel Co Ltd Class A SHG:601005	0.058x
Cellcom Israel Ltd TA:CEL	0.111x
YGSOFT Inc SHE:002063	0.011x
Peoples Bancorp Inc NASDAQ:PEBO	0.045x
Peugeot Invest SA PA:PEUG	-0.013x
Aerospace Nanhu Electronic Information Technology Co. Ltd. A SHG:688552	N/A
NÜRNBERGER Beteiligungs-AG F:NBG6	-0.113x

Annual Cash Flow Conversion Efficiency for Nanobiotix S.A (2011–2024)

The table below shows the annual cash flow conversion efficiency of Nanobiotix S.A from 2011 to 2024. Review Nanobiotix S.A free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-65.70 Million ≈ $-76.81 Million	€-19.55 Million ≈ $-22.86 Million	0.298x	-95.60%
2023-12-31	€-1.84 Million ≈ $-2.15 Million	€-12.48 Million ≈ $-14.59 Million	6.769x	+393.43%
2022-12-31	€-27.05 Million ≈ $-31.62 Million	€-37.10 Million ≈ $-43.38 Million	1.372x	+218.11%
2021-12-31	€26.69 Million ≈ $31.21 Million	€-31.00 Million ≈ $-36.25 Million	-1.162x	-189.43%
2020-12-31	€70.36 Million ≈ $82.26 Million	€-28.24 Million ≈ $-33.01 Million	-0.401x	-101.97%
2019-12-31	€-2.04 Million ≈ $-2.38 Million	€-41.52 Million ≈ $-48.54 Million	20.362x	+1216.11%
2018-12-31	€14.24 Million ≈ $16.65 Million	€-25.98 Million ≈ $-30.38 Million	-1.824x	-282.51%
2017-12-31	€43.92 Million ≈ $51.35 Million	€-20.95 Million ≈ $-24.49 Million	-0.477x	+54.61%
2016-12-31	€17.40 Million ≈ $20.34 Million	€-18.28 Million ≈ $-21.38 Million	-1.051x	+2.47%
2015-12-31	€15.61 Million ≈ $18.25 Million	€-16.82 Million ≈ $-19.66 Million	-1.077x	-281.37%
2014-12-31	€30.32 Million ≈ $35.44 Million	€-8.56 Million ≈ $-10.01 Million	-0.283x	+86.84%
2013-12-31	€3.18 Million ≈ $3.72 Million	€-6.83 Million ≈ $-7.99 Million	-2.147x	-506.57%
2012-12-31	€10.70 Million ≈ $12.51 Million	€-3.79 Million ≈ $-4.43 Million	-0.354x	+93.28%
2011-12-31	€925.53K ≈ $1.08 Million	€-4.87 Million ≈ $-5.70 Million	-5.265x	--

About Nanobiotix S.A

PA:NANO France Biotechnology

Market Cap

$1.59 Billion

€1.36 Billion EUR

Market Cap Rank

#7254 Global

#124 in France

Share Price

€28.12

Change (1 day)

-7.26%

52-Week Range

€15.76 - €46.18

All Time High

€46.18